etidronate has been researched along with Biliary Cirrhosis in 5 studies
Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate effectively increases bone mass and has greater antiresorptive power than etidronate in patients with primary biliary cirrhosis, and is associated with minor or no side effects." | 9.10 | Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. ( Alvarez, L; Caballería, L; Guañabens, N; Martínez de Osaba, MJ; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Ros, I, 2003) |
| "Cyclical etidronate administered with supplemental calcium did not significantly improve bone density in patients with primary biliary cirrhosis." | 9.09 | Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. ( Dickson, ER; Jorgensen, RA; Khosla, S; Lindor, KD; Tiegs, RD, 2000) |
| "Twelve primary biliary cirrhosis patients (all Child-Pugh Class A), treated with prednisone in the context of a 1-year placebo-controlled pilot study with prednisone (maintenance dose 10 mg daily), and azathioprine (50 mg daily), were randomized to receive either cyclical etidronate (400 mg daily, during 2 weeks) alternated with calcium 500 mg daily during 11 weeks or calcium alone." | 9.08 | Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. ( den Ouden, JW; Hop, WC; Pols, HA; Schalm, SW; van Buuren, HR; van Leeuwen, JP; Wolfhagen, FH, 1997) |
| "Because osteopenia increases morbidity of primary biliary cirrhosis (PBC), the effects of cyclical etidronate vs." | 9.08 | Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. ( Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M, 1997) |
| "Alendronate effectively increases bone mass and has greater antiresorptive power than etidronate in patients with primary biliary cirrhosis, and is associated with minor or no side effects." | 5.10 | Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis. ( Alvarez, L; Caballería, L; Guañabens, N; Martínez de Osaba, MJ; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Ros, I, 2003) |
| "Cyclical etidronate administered with supplemental calcium did not significantly improve bone density in patients with primary biliary cirrhosis." | 5.09 | Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial. ( Dickson, ER; Jorgensen, RA; Khosla, S; Lindor, KD; Tiegs, RD, 2000) |
| "Twelve primary biliary cirrhosis patients (all Child-Pugh Class A), treated with prednisone in the context of a 1-year placebo-controlled pilot study with prednisone (maintenance dose 10 mg daily), and azathioprine (50 mg daily), were randomized to receive either cyclical etidronate (400 mg daily, during 2 weeks) alternated with calcium 500 mg daily during 11 weeks or calcium alone." | 5.08 | Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study. ( den Ouden, JW; Hop, WC; Pols, HA; Schalm, SW; van Buuren, HR; van Leeuwen, JP; Wolfhagen, FH, 1997) |
| "Because osteopenia increases morbidity of primary biliary cirrhosis (PBC), the effects of cyclical etidronate vs." | 5.08 | Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years. ( Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M, 1997) |
| "Patients with primary biliary cirrhosis often have osteoporosis - either postmenopausal or secondary to the liver disease." | 2.47 | Bisphosphonates for osteoporosis in primary biliary cirrhosis. ( Bjelakovic, G; Giljaca, V; Gluud, C; Krstic, MN; Rudic, JS, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rudic, JS | 1 |
| Giljaca, V | 1 |
| Krstic, MN | 1 |
| Bjelakovic, G | 1 |
| Gluud, C | 1 |
| Guañabens, N | 2 |
| Parés, A | 2 |
| Ros, I | 1 |
| Alvarez, L | 2 |
| Pons, F | 2 |
| Caballería, L | 1 |
| Monegal, A | 2 |
| Martínez de Osaba, MJ | 1 |
| Roca, M | 2 |
| Peris, P | 2 |
| Rodés, J | 2 |
| Wolfhagen, FH | 1 |
| van Buuren, HR | 1 |
| den Ouden, JW | 1 |
| Hop, WC | 1 |
| van Leeuwen, JP | 1 |
| Schalm, SW | 1 |
| Pols, HA | 1 |
| de Osaba, MJ | 1 |
| Torra, M | 1 |
| Lindor, KD | 1 |
| Jorgensen, RA | 1 |
| Tiegs, RD | 1 |
| Khosla, S | 1 |
| Dickson, ER | 1 |
1 review available for etidronate and Biliary Cirrhosis
| Article | Year |
|---|---|
Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Topics: Alendronate; Bone Density Conservation Agents; Diphosphonates; Etidronic Acid; Female; Humans; Iband | 2011 |
4 trials available for etidronate and Biliary Cirrhosis
| Article | Year |
|---|---|
Alendronate is more effective than etidronate for increasing bone mass in osteopenic patients with primary biliary cirrhosis.
Topics: Adult; Aged; Alendronate; Bone Density; Bone Remodeling; Densitometry; Dose-Response Relationship, D | 2003 |
Cyclical etidronate in the prevention of bone loss in corticosteroid-treated primary biliary cirrhosis. A prospective, controlled pilot study.
Topics: Adrenal Cortex Hormones; Adult; Aged; Bone Density; Double-Blind Method; Etidronic Acid; Female; Hum | 1997 |
Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Drug Administration Schedule; Etidro | 1997 |
Etidronate for osteoporosis in primary biliary cirrhosis: a randomized trial.
Topics: Adult; Aged; Biomarkers; Bone Density; Bone Remodeling; Calcium; Collagen; Collagen Type I; Drug The | 2000 |